These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 30096496)

  • 1. Intracranial Hemorrhage After Superficial Temporal Artery-Middle Cerebral Artery Direct Anastomosis for Adults with Moyamoya Disease.
    Park W; Park ES; Lee S; Park JC; Chung J; Lee JM; Ahn JS
    World Neurosurg; 2018 Nov; 119():e774-e782. PubMed ID: 30096496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of Quantitative Cerebral Blood Flow Measurement in the Acute Stage after Revascularization Surgery for Adult Moyamoya Disease: Implication for the Pathological Threshold of Local Cerebral Hyperperfusion.
    Kameyama M; Fujimura M; Tashiro R; Sato K; Endo H; Niizuma K; Mugikura S; Tominaga T
    Cerebrovasc Dis; 2019; 48(3-6):217-225. PubMed ID: 31812964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and Risk Factors of the Watershed Shift Phenomenon after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis for Adult Moyamoya Disease.
    Tashiro R; Fujimura M; Kameyama M; Mugikura S; Endo H; Takeuchi Y; Tomata Y; Niizuma K; Tominaga T
    Cerebrovasc Dis; 2019; 47(3-4):178-187. PubMed ID: 31121577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Cerebral Hyperperfusion after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis by Three-Dimensional-Time-of-Flight Magnetic Resonance Angiography in Adult Patients with Moyamoya Disease.
    Nishizawa T; Fujimura M; Katsuki M; Mugikura S; Tashiro R; Sato K; Tominaga T
    Cerebrovasc Dis; 2020; 49(4):396-403. PubMed ID: 32829323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography.
    Fujimura M; Shimizu H; Inoue T; Mugikura S; Saito A; Tominaga T
    Neurosurgery; 2011 Apr; 68(4):957-64; discussion 964-5. PubMed ID: 21221039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Hyperspectral Imaging System for Intraoperative Prediction of Cerebral Hyperperfusion Syndrome after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis in Patients with Moyamoya Disease.
    Iwaki K; Takagishi S; Arimura K; Murata M; Chiba T; Nishimura A; Ren N; Iihara K
    Cerebrovasc Dis; 2021; 50(2):208-215. PubMed ID: 33596563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between reduction in microvascular transit time after superficial temporal artery-middle cerebral artery bypass surgery for moyamoya disease and the development of postoperative hyperperfusion syndrome.
    Yang T; Higashino Y; Kataoka H; Hamano E; Maruyama D; Iihara K; Takahashi JC
    J Neurosurg; 2018 May; 128(5):1304-1310. PubMed ID: 28498060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biphasic Development of Focal Cerebral Hyperperfusion After Revascularization Surgery for Adult Moyamoya Disease Associated With Autosomal Dominant Polycystic Kidney Disease.
    Tashiro R; Fujimura M; Endo H; Endo T; Niizuma K; Tominaga T
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3256-3260. PubMed ID: 30093201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minocycline prevents focal neurological deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease.
    Fujimura M; Niizuma K; Inoue T; Sato K; Endo H; Shimizu H; Tominaga T
    Neurosurgery; 2014 Feb; 74(2):163-70; discussion 170. PubMed ID: 24176958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease.
    Fujimura M; Kaneta T; Mugikura S; Shimizu H; Tominaga T
    Surg Neurol; 2007 Mar; 67(3):273-82. PubMed ID: 17320638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease.
    Fujimura M; Mugikura S; Kaneta T; Shimizu H; Tominaga T
    Surg Neurol; 2009 Apr; 71(4):442-7. PubMed ID: 18514264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superficial temporal artery-to-middle cerebral artery bypass in combination with indirect revascularization in moyamoya patients ≤ 3 years of age.
    Bot GM; Burkhardt JK; Gupta N; Lawton MT
    J Neurosurg Pediatr; 2019 Feb; 23(2):198-203. PubMed ID: 30497164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent Local Vasogenic Edema with Dynamic Change in the Regional Cerebral Blood Flow after STA-MCA Bypass for Adult Moyamoya Disease.
    Kawamura K; Fujimura M; Tashiro R; Kanoke A; Saito A; Tominaga T
    J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104625. PubMed ID: 31952980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors of symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in adult patients with moyamoya disease.
    Hwang JW; Yang HM; Lee H; Lee HK; Jeon YT; Kim JE; Lim YJ; Park HP
    Br J Anaesth; 2013 May; 110(5):773-9. PubMed ID: 23274781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-operative hemorrhage due to hyperperfusion during direct revascularization surgery in an adult patient with moyamoya disease: a case report.
    Uchida H; Endo H; Fujimura M; Endo T; Niizuma K; Tominaga T
    Neurosurg Rev; 2017 Oct; 40(4):679-684. PubMed ID: 28600750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-operative higher hematocrit and lower total protein levels are independent risk factors for cerebral hyperperfusion syndrome after superficial temporal artery-middle cerebral artery anastomosis with pial synangiosis in adult moyamoya disease patients-case-control study.
    Katsuki M; Fujimura M; Tashiro R; Tomata Y; Nishizawa T; Tominaga T
    Neurosurg Rev; 2021 Aug; 44(4):2191-2200. PubMed ID: 32968846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of aneurysms in patients with moyamoya disease: a 10-year single-center experience.
    Ni W; Jiang H; Xu B; Lei Y; Yang H; Su J; Gu Y; Mao Y
    J Neurosurg; 2018 Jun; 128(6):1813-1822. PubMed ID: 28841118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined STA-MCA Bypass and Encephalodurosynangiosis Versus Encephalodurosynangiosis Alone in Adult Hemorrhagic Moyamoya Disease: A 5 -Year Outcome Study.
    Zhang M; Raynald ; Zhang D; Liu X; Wang R; Zhang Y; Zhao J
    J Stroke Cerebrovasc Dis; 2020 Jun; 29(6):104811. PubMed ID: 32312630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-of-Flight MR Angiography for Detection of Cerebral Hyperperfusion Syndrome after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis in Moyamoya Disease.
    Sato K; Yamada M; Kuroda H; Yamamoto D; Asano Y; Inoue Y; Fujii K; Kumabe T
    AJNR Am J Neuroradiol; 2016 Jul; 37(7):1244-8. PubMed ID: 26939637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfusion-weighted magnetic resonance imaging used in assessing hemodynamics following superficial temporal artery-middle cerebral artery bypass in patients with Moyamoya disease.
    Li Z; Zhou P; Xiong Z; Ma Z; Wang S; Bian H; Chen J
    Cerebrovasc Dis; 2013; 35(5):455-60. PubMed ID: 23735877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.